All countries have patent safeguards and have the right and ability to implement compulsory licensing in emergency circumstances...It is important for India and the rest of the world to have a good balance between implementation of innovation policies and those that give better access to medicine. There is no conflict between a patent system and the public’s access to medicines. [refers to Dr Reddy’s, Ranbaxy]